NT: You are not a stock analyst, Jason is. In fact, he is the one Gerald always allows to ask the first question at the CCs. Gerald knows of Jason's 1 million revenue estimate for 2015 and yet he allowed him to ask most of the questions in yesterday's CC ....instead of allowing any shareholders. You can't so easily dismiss what Jason says.
If Jason says Lympro will only make 1 million in 2015 and only 3.5 million in 2016 and Gerald says nothing about it....Houston, we've got a problem!!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links